A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 With Influenza Vaccine in Adults ≥ 50 Years of Age
Clinical trial NCT07365826 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07365826
- Sponsor
- Vaxcyte, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-12
- Primary completion
- 2027-03-01
- Enrollment
- 1390
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.